KCT0004917已完成未知
Open-labeled, comparative study to evaluate the efficacy and safety of Kislip
Kyung Hee University Hosipital at Gangdong0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 25(Year) 至 45(Year)（—）
- 性别
- Male
入选标准
- •1) Healthy adult males aged 25 to 45 at the time of the screening test
- •2) Those who are over 45 kg and are within ± 20% of the ideal body weight.
- •* Ideal body weight = (height cm – 100) x 0.9
- •3) Those who have more than 1 bottle of soju and have experienced hangover
- •4) A person who, after receiving sufficient explanation for this human application test, voluntarily decides to participate and agrees in writing to observe the precautions
排除标准
- •1) Those who show symptoms of acute disease 28 days before the start of the test (injection of human body test food)
- •2) A person with a history (e.g., inflammatory gastrointestinal disease, gastric or duodenal ulcer, gastrointestinal treatment, and liver disease) that can affect the absorption, distribution, metabolism and excretion of food for human applications.
- •3) A person with clinically significant gastrointestinal tract, cardiovascular system, respiratory system, kidney, endocrine system, haematological, digestive system, central nervous system, mental illness, or malignant tumor
- •4) A person who is deemed unfit for the study through a medical examination within 28 days of the initiation of a test (injection of food for human body testing) (inclusion of diseases, physical examination, clinical pathological examination, etc.)
- •5) Has or is currently active with a history of gastric or duodenal ulcers in the past
- •a man with a gastric ulcer
- •6) In a laboratory test or vital signs, a person who shows any of the following results:
- •a. AST (SGOT) or ALT (SGPT) > Twice the normal range limit
- •b. Total bilirubin > Twice the upper normal range limit
- •7) A person with clinically significant allergic diseases (except minor allergic rhinitis that does not require administration)
- •8) Anyone who is hypersensitive to alcohol or has a history of alcoholism.
- •9) Those who participated in other clinical studies within 60 days of the commencement of testing (injection of food for human body testing) as subjects of study
- •10) Those who take drugs that induce and inhibit metabolic enzymes, such as barbital drugs, within 30 days prior to the start of the test (injection of food for human body testing) or within 10 days (injection of food for human body testing) or within five times the half-life of those who take drugs that will affect human testing
- •11) Systolic blood pressure > 140 mmHg, relaxed blood pressure >90 mmHg or higher
- •12) Those with increased guide pressure or who suffer from or suffer from glaucoma, urinary fluid, etc.
- •13) A person who has been eating an abnormal diet that may affect absorption, distribution, metabolism and excretion of alcohol or functional food.
- •14) Those who cannot eat standard meals provided by Kang Dong Kyung Hee University Hospital
- •15) A person who gives full blood within 60 days of the start of the test (injecting human body test food) or a person who gives component blood within 30 days of the start of the test
- •16) Continuous caffeine (Caffeine >5 cups/day), drinking (Alcohol >30g/day) or smoking or excessive smokers (cigarette >10/day)
- •17) A person who determines that the tester is unfit to participate in the human testing due to other reasons, including laboratory test results.
- •18) Person who cannot read letters or whose ability is limited (illiterate)
研究者
相似试验
已完成
不适用
An open-label comparative study to evaluate the effectiveness of video education during outpatient waiting time in chronic kidney diseasechronic kidney diseaseJPRN-UMIN000045882Chiba University Hospital50
已完成
3 期
Clinical trial on patients with menorrhagiaCTRI/2023/01/049258Jagdale industries pvt Ltd60
尚未招募
2 期
A study to find out the effect of thermal microcautery and vital point stimulation in frozen shoulder.CTRI/2024/07/070014Dr Aswathy K
已完成
不适用
Study of dietary fiber supplement to improve triglycerides and plasma glucose levels in subjects with elevated LDL levels.CTRI/2012/12/003220Spectrum Clinical Research Pvt Ltd60
招募中
2 期
Restoring of normal skin color using Manjishta lepa on scarCTRI/2022/09/045896Sri Dharmasthala Manjunatheshwara College of Ayurveda Kuthpady Udupi